Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Subst Abuse Treat. 2014 Dec 22;52:40–47. doi: 10.1016/j.jsat.2014.12.002

CINAHL (Ebsco)

# Query Results
S10 S3 AND S6 AND S9 39
S9 S7 OR S8 49,529
S8 nicotine OR Tobacco* OR smok* OR cigar* OR snuff OR e-cigar* 49,529
S7 (MH “Smoking+”) OR (MH “Tobacco+”) OR (MH “Nicotine Withdrawal”) OR (MH “Nicotine”) 33,793
S6 S4 OR S5 5,232
S5 LAAM OR “l-alpha-acetylmethydol” OR “l-alpha-acetylmethadol” OR “levo-alpha-acetylmethadol” OR “levo-alpha-acetylmethydol” OR Opioid substitut* OR opioid replace* OR Opiate substitut* OR opiate replace* OR Methadone OR Buprenorphine OR subutex OR buprenex OR butrans OR suboxone OR narcotic antagonist* OR Butorphanol OR Naltrexone OR Naloxone OR narcan 5,165
S4 (MH “Buprenorphine”) OR (MH “Methadone”) OR (MH “Narcotic Antagonists+”) 4,232
S3 S1 OR S2 126,586
S2 Pregnant OR pregnancy OR pregnancies OR prenatal OR Fetus OR foetus OR foetal OR fetal OR Placenta* OR “in utero” OR maternal OR perinatal 121,502
S1 (MH “Prenatal Exposure Delayed Effects”) OR (MH “Pregnancy+”) OR (MH “Pregnancy Trimesters+”) OR (MH “Expectant Mothers”) OR (MH “Pregnancy Complications+”) OR (MH “Maternal Exposure”) OR (MH “Fetus+”) OR (MH “Placenta+”) OR (MH “Neonatal Abstinence Syndrome”) 99,804
HHS Vulnerability Disclosure